Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan:146:110439.
doi: 10.1016/j.mehy.2020.110439. Epub 2020 Nov 28.

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

Andy Goren  1 , Flavio Adsuara Cadegiani  2 , Carlos Gustavo Wambier  3 , Sergio Vano-Galvan  4 , Antonella Tosti  5 , Jerry Shapiro  6 , Natasha Atanaskova Mesinkovska  7 , Paulo Müller Ramos  8 , Rodney Sinclair  9 , Omar Lupi  10 , Jana Hercogova  11 , John McCoy  1
Affiliations
Comment

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

Andy Goren et al. Med Hypotheses. 2021 Jan.
No abstract available

Keywords: Androgen receptor; Androgenetic alopecia; COVID-19; Gabrin sign; SARS-CoV-2; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Theoretical Androgen Receptor modulation of humoral and cell-mediated immune response. Dihydrotestosterone (DHT) increases androgen expression and may cause a decrease in the protective immune response for SARS-CoV-2.
See this image and copyright information in PMC

Comment on

References

    1. Ibarrondo F.J., Fulcher J.A., Goodman-Meza D. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild covid-19. N Engl J Med. 2020;383(11):1085–1087. doi: 10.1056/NEJMc2025179. - DOI - PMC - PubMed
    1. Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther 2020:e13365. doi:10.1111/dth.13365. - PMC - PubMed
    1. Wambier C.G., Vaño-Galván S., McCoy J. Androgenetic alopecia present in the majority of hospitalized COVID-19 patients – the “Gabrin sign”. J Am Acad Dermatol. 2020 doi: 10.1016/j.jaad.2020.05.079. - DOI - PMC - PubMed
    1. Altuwaijri S., Chuang K.-H., Lai K.-P. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol Endocrinol. 2009;23(4):444–453. doi: 10.1210/me.2008-0106. - DOI - PMC - PubMed
    1. Hepworth M.R., Hardman M.J., Grencis R.K. The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection. Eur J Immunol. 2010;40(2):406–416. doi: 10.1002/eji.200939589. - DOI - PMC - PubMed